Alfresa agrees unit merger, while JPY 788.96 billion revenue shapes Alfresa stock

Published on 10/25/2026 at 02:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alfresa agreed on September 29 to merge two wholly owned units. Alfresa stock posted JPY 788.96 billion in first-quarter revenue for fiscal 2027.

Merger and quarterly scale

Alfresa agreed on September 29, 2026, to merge two wholly owned subsidiaries.
First-quarter fiscal 2027 revenue reached JPY 788.96 billion, up 6.48 percent from JPY 740.98 billion.
Alfresa Holdings stock closed at JPY 2,406.50 on Japan Exchange on October 23, 2026.
Alfresa Holdings is scheduled to release second-quarter fiscal 2027 results on November 8, 2026.

Alfresa, JP3126340003, Illustration mit AI erstellt.

Alfresa agreed on September 29, 2026, to merge two wholly owned subsidiaries, while first-quarter fiscal 2027 revenue reached JPY 788.96 billion. The official Alfresa Corporation notice ties the move to stronger operating foundations in the Kyushu area, giving Alfresa stock a concrete operational event to assess.

Merger strengthens regional operations

The September 29 agreement concerns two wholly owned companies operating in ethical pharmaceuticals wholesaling. Alfresa's English-language notice describes the transaction as a way to strengthen operating foundations in Kyushu, a region where distribution scale matters for hospitals, clinics and pharmacies.

The chronology started with first-quarter results released on August 5, 2026. On September 2, Alfresa, 12 Pharmacy and animo agreed on a basic arrangement to commercialize a next-generation veterinary healthcare platform, before the September 29 merger agreement brought the latest corporate-development update.

What did first quarter show?

Investing.com reports first-quarter fiscal 2027 revenue of JPY 788.96 billion, compared with JPY 740.98 billion in the previous quarter. That is a 6.48 percent increase. Net income was JPY 2.476 billion, down from JPY 9.765 billion in the previous quarter, a 74.65 percent decline.

The contrast matters because Alfresa operates on thin distribution margins. Revenue expanded, but the quarterly earnings contribution fell sharply, leaving the regional merger and the next results as the more useful tests of execution than sales growth alone.

Two dates guide the next update

The next substantiated date is November 8, 2026, when Alfresa is scheduled to release second-quarter fiscal 2027 results, according to MarketScreener. The September 29 merger agreement is the latest dated corporate event, and the August 5 quarterly release supplies the operating benchmark for that update.

Stock keeps the results in view

Alfresa Holdings stock closed at JPY 2,406.50 on Japan Exchange on October 23, 2026, according to the quoted market page. The combination of a regional distribution merger, JPY 788.96 billion in quarterly revenue and JPY 2.476 billion in net income gives the November report a clear measuring point.